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Objectives: To identify whether abdominal aortic aneurysm screening causes anxiety in those screened and whether the 
diagnosis of an aneurysm produces ustained anxiety in subjects in comparison with those in whom no abnormality is 
detected. 
Design: Prospective case controlled study. 
Materials and Methods: The 28-item General Health Questionnaire (GHQ) was used to assess psychological morbidity 
in 161 men attending for routine aneurysm screening in the Gloucestershire Aneurysm Screening Programme. One 
hundred men had a normal aorta and 61 were identified as having aneurysms. The GHQ was administered just before 
screening and 1 month later. An anxiety linear analogue scale was also used. 
Results: There was no difference in anxiety levels between those men with normal aortas and those with aneurysms 
either before or after screening. There was a statistically significant reduction in both these groups 1 month after screening. 
Conclusion: This study shows that although the invitation to aneurysm screening may cause some mild anxiety, this is 
not prolonged even when an asymptomatic aneurysm is diagnosed. 
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Introduction 
Concern has been expressed that screening for any 
condition may have adverse psychological effects. The 
invitation to screening may make men aware of their 
vulnerability to a potentially fatal condition. Once a 
diagnosis of a small aneurysm has been made which 
does not require surgery, the individual's anxiety 
might not be alleviated. They might feel that their 
everyday activities hould be curtailed in some way 
analogous to patients who have had a myocardial 
infarct or who have been screened and found to have 
mild hypertension. 
In order to investigate these issues this study set 
out to determine immediate and persistent psychiatric 
morbidity in men undergoing screening, and in those 
referred for further follow up because of the diagnosis 
of an abdominal aortic aneurysm. 
Methods 
As part of the Gloucestershire Aneurysm Screening 
Programme 10 145 men born between 1925 and 1928 
* Please address all correspondence to: B. Po Heather, Consultant 
Surgeon, Gloucestershire Royal Hospital, Great Western Road, Glou- 
cester, GL1 3NN, U.K. 
and appearing in the Family Practitioner Committee 
records of 87 Gloucestershire practices were invited 
for screening during the period September 1990-June 
1994. Patients were invited by their general practitioner 
to attend the surgery for screening by a mobile unit. 
A preliminary invitation and information letter were 
sent out before the screening date. In addition, for the 
period of the study individuals were asked on arrival 
at the screening clinic to complete the 28-item version 
of the General Health Questionnaire 1 by the aneurysm 
screening co-ordinator (ES). The GHQ is brief and 
acceptable and provides a valid measure of com- 
parison between groups where the object is to detect 
anxiety or depression offairly recent onset. A condition 
placed on the psychological study was that it should 
not reduce compliance or interfere with the efficiency 
of the screening programme. The permission of the 
general practitioners tocirculate the questionnaire was 
sought prior to screening. Only four practices refused 
to allow circulation of the questionnaire. 
The patients were also asked to mark on a linear 
analogue scale from 1-80 where they felt they were 
in terms of anxiety, where one represented "not at all 
anxious" and 80 "very anxious". They were also asked 
questions regarding their understanding of the screen- 
ing process. 
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Table 1. Differences between ormal and abnormal groups in GHQ score. 
Difference 95% Confidence p-value 
(Group 1-Group 2) interval 
Pre-screen scores -0.19 -3.01 to 2.62 0.89 
Post-screen scores 0.11 -2.27 to 2.50 0.92 
Table 2. Differences between pre- and post-screening GHQ scores in normal and abnormal groups. 
Group 1 (normal patients) 
Number Mean 95% Confidence S.D. p-value 
interval 
Pre- 100 15.51 13.71 to 17.37 9.17 
Post- 100 14.36 12.93 to 15.79 7.28 
Difference 100 - 1.15 - 0.14 to - 2.16 6.16 0.03 
Group 2 (abnormal patients) 
Number Mean 95% Confidence S.D. p-value 
interval 
Pre- 61 15.71 13.67 to 17.74 9.13 
Post- 61 14.25 12.32 to 16.17 7.68 
Difference 61 - 1.46 - 0.08 to - 2.84 5.49 0.04 
All patients were informed of the result of their scan 
by the screening co-ordinator (ES) who attended all 
sessions. Additional information sheets with a contact 
telephone number  for the co-ordinator and an ex- 
planation of planned follow-up were provided for all 
patients with aortic diameters greater than 2.5 cm. 
Patients with aortic diameters of 4 cm and above were 
referred for out-patient assessment within 2 weeks by 
a consultant surgeon with a vascular interest. 
One month later the first 100 men who had normal 
aortas and 61 with a diagnosed aneurysm were again 
asked to complete the GHQ-28 and linear analogue 
scale by post. The GHQ score and scales were com- 
pared between the two groups before and 1 month 
after screening. The statistical methods used in this 
study were the Student's unpaired t-test to test for 
statistical significance of differences between groups 
(normal and abnormal aortic diameter) and the paired 
t-test o test for any significant change in anxiety score 
as a result of screening in each group. 
Results 
One hundred men with normal aortas (group 1) and 
61 men with enlarged aortas (group 2) filled out ques- 
tionnaires before and one month after screening. Nine 
refused to complete them. Four were unfit to complete 
them. 
GHQ scores showed no difference between groups 
before and 1 month after screening (Table 1). There 
was a statistically significant fall in anxiety levels in 
both groups 1 month after screening (Table 2). 
On the linear analogue scale 122 men of 156 (78%) 
recorded a value between 1 and 20 prior to screening. 
Five men did not complete this part of the ques- 
tionnaire. At 1 month after screening 119 of 154 (77%) 
recorded a value between i and 20, a further two men 
did not complete this part of the questionnaire. There 
was no difference before or after screening between 
the two groups using linear analogue scale. 
Over 90% of men found the information sheet help- 
ful and informative. Over 95% had a clear idea of the 
reasons for aortic aneurysm screening and over 95% 
clearly understood that the screening test might result 
in the recommendat ion f an operation. 
Discussion 
The ideal screening programme should identify an 
abnormality associated with significant potential mor- 
tality that is not otherwise detectable. It should be 
without side effects and treatment should be available 
that can restore patients to normality. 
Abnormal  aortic aneurysm screening fulfils these 
criteria, except that the question of possible psy- 
chological morbidity induced by screening has not 
been addressed. 
All screening for asymptomatic disease may carry 
psychological morbidity. 2'3 Unlike breast cancer, an- 
eurysmal dilation of the aorta has the advantage that 
it can be detected before it is clinically significant and 
whilst surgery can still influence the natural history 
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of the disease. Also, in aortic aneurysm screening the 
result of the ultrasound scan is given immediately 
without increasing anxiety awaiting results. Questions 
have been raised as to the effectiveness of breast cancer 
screening, particularly when weighed against he not 
insignificant morbidity of repeated mammography 
and negative breast biopsy3 
The GHQ was designed to be a self-administered 
screening test aimed at detecting psychiatric disorders 
among respondents in non-psychiatric clinical settings 
and in the community. It is easy to administer, ac- 
ceptable to respondents, fairly short and objective in 
that it does not require the person administering it to 
make subjective assessments about the respondent. It 
is aimed at detecting those forms of disorder that may 
have relevance to a patient's presence in a medical 
clinic. It has been used in 38 languages and over 40 
validity studies have been published. 1 
It has been used in assessing psychological mor- 
bidity in breast screening. 3 It has correlated higher 
scores with increased narcotic use after chole- 
cystectomy 5 and worse symptoms of irritable bowel 
syndrome. 6 It has demonstrated a curvi-linear re- 
lationship between GHQ scores and survival in 
patients with ischaemic heart disease. 7 
Large scale population screening for asymptomatic 
aortic aneurysms has been shown to be productive 
and practical. 8 In this study, the first of its kind, we 
have shown screening for aortic aneurysms does not 
cause unacceptable psychological morbidity even 
where an asymptomatic aneurysm is diagnosed. 
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